Find the insider trades that matter

Search insider filings by company or ticker, spot unusual buying across global markets, and get alerts for the stocks you follow.

Clear filters

PolyPeptide Group AG (PPGN)

Switzerland · Pharmaceuticals & Medical Research

All companies
Purchases
0
Purchase value (USD)
$0
Sales
6
Sale value (USD)
$18,449,091

Reported in the past 7 days. USD totals include transactions with a recorded USD value; planned trades are excluded from these totals.

Latest insider trades

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Insider
Executive Director / Officer
Price
44.31
Quantity 227,842
Value CHF10,095,679
Transaction date
Sale
Insider
Non-Executive Director
Price
44.42
Quantity 3,193
Value CHF141,819
Transaction date
Sale
Insider
Non-Executive Director
Price
44.31
Quantity 4,290
Value CHF190,090
Transaction date
Sale
Insider
Non-Executive Director
Price
44.31
Quantity 29,702
Value CHF1,316,096
Transaction date
Sale
Insider
Non-Executive Director
Price
44.31
Quantity 32,813
Value CHF1,453,944
Transaction date
Sale
Insider
Non-Executive Director
Price
44.31
Quantity 45,319
Value CHF2,008,085
More transactions
Company B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value
S Sale Executive Director / Officer
227,842
44.31
CHF10,095,679 		227,842 44.31 CHF10,095,679
S Sale Non-Executive Director
3,193
44.42
CHF141,819 		3,193 44.42 CHF141,819
S Sale Non-Executive Director
4,290
44.31
CHF190,090 		4,290 44.31 CHF190,090
S Sale Non-Executive Director
29,702
44.31
CHF1,316,096 		29,702 44.31 CHF1,316,096
S Sale Non-Executive Director
32,813
44.31
CHF1,453,944 		32,813 44.31 CHF1,453,944
S Sale Non-Executive Director
45,319
44.31
CHF2,008,085 		45,319 44.31 CHF2,008,085
More transactions
View full transaction feed →

Activity signals

Latest reported activity in your selected markets

Company ActivityInsidersNet insider flow (USD)Reported
Unusual buying cluster——5 Nov
Unusual buying cluster——5 Nov
SE Ambea AB (publ) (AMBEA)
First insider selling in 6 months——5 Nov
First insider selling in 2 years, 2 months——5 Nov
First insider buying in 9 months——5 Nov
View all: Activity signals →

Worth reviewing this week

Past 7 days All activity signals →

Track insider activity the way you invest

Built around the workflows of serious investors — not raw regulatory feeds.

Screeners

Pre-built screens for every strategy

Surface unusual activity instantly with top insider buys, cluster buys, largest buys, and executive buy screens — updated daily across all markets.

  • Top insider buys — strongest buy signals ranked by conviction
  • Cluster buys — multiple insiders buying same company
  • Largest buys — highest-value purchase transactions
  • Executive buys — CEO, CFO, COO purchases only
Screeners
Top insider buysMost popular
Cluster buys
Largest buys
Executive buys
See more screeners
Alerts

Daily and real-time alerts, your way

Get notified the moment a relevant trade is filed. Track companies, specific insiders, or custom screener results — delivered by email or in-app.

  • Company watchlist alerts
  • Insider-specific trade alerts
  • Screener result digests
  • Real-time alerts (Premium)
Daily reportDelivered 7:00 AM
LVMH · Bernard Arnault, Chairman and CEO
Buy ✓ At market price
€10M
Constellation Software · Mark Miller, CEO
Buy ✓ At market price
CA$4.9M
SAP SE · Christian Klein, CEO
Buy ✓ At market price
€100,000
Global coverage

One platform, 16 markets worldwide

Track insider activity from the US, UK, EU, India, Canada, Spain and more — all in one place with standardised transaction fields across every market.

  • US SEC filings (Forms 4, 144)
  • UK, Germany, France, Sweden, Italy
  • India, Canada, Spain & more
  • Standardised fields across all markets
Selected markets
CH Switzerland BE Belgium FI Finland DK Denmark NL Netherlands IT Italy GR Greece AU Australia KR South Korea
Data quality

Noise-filtered data for serious investors

Not all insider trades are investment signals. We classify each transaction as relevant or routine — so you focus on meaningful buying and selling, not automatic plan executions.

  • Relevant vs. routine transaction tagging
  • Auto-plan (10b5-1) and market price filtering
  • Cluster detection across filing dates
  • Daily data refresh from regulatory sources
Transaction classification
LVMH · Bernard Arnault, CEO
CEO-linked purchase
Relevant €35M
JPMorgan Chase · Jamie Dimon, CEO
CEO share sale
Relevant US$21.4M
NVIDIA · Colette Kress, CFO
Planned sale
Routine US$8.5M
Apple · Tim Cook, CEO
Planned sale
Routine US$33M

Trusted by investors worldwide

"

"Insider Screener offers the best tool for identifying and monitoring insider activity I've found on the web, hard stop. Several of my top-performing buys came from identifying, researching and analyzing companies on found using this site I otherwise would have missed. I strongly recommend Insider Screener - only wish I found it sooner!"

John G. Alexander, CFA
Chief Investment Officer/Sr. Portfolio Mgr
"

"I have been using Insider Screener for a long time, and I’m very pleased with the insights it provides. The great thing about this platform is that it offers data and insights not only for the US market but for other markets as well. I use it in my daily analysis and am truly grateful for this platform. Additionally, the customer service is excellent—any issues are resolved promptly, and they are always updating the platform with new features."

NTK Kotian
Trader
"

"Incredibly useful tool for monitoring corporate insider transactions... simple interface, highly customizable screens, customizable daily alerts."

Duane
Portfolio Manager

Start tracking insider trades today

Join hundreds of investors using insider screener to uncover actionable signals from global regulatory filings.

Start tracking insider trades → View latest transactions